Arcus Biosciences Shares Rise After Kidney Cancer Drug Shows Promise in Early-Stage Trial

The Hayward, Calif., biopharmaceutical company’s shares were up 13% to $19.50 in premarket trading. Of… By Rob Curran. Shares of Arcus …

Do you trust this headline?

Based on recent headline ratings, 86% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positive.

86%

Media Trust Score86%

In